Metraipolis › archive › dc_d6bf545e86e6
Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2… — Europe PMC PMID:42420629
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42420629
- DOI
- 10.1038/s41416-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T09:59:21.180Z
- SHA-256 of the archived text
2060f48a9976805abdc9f668873df9e4ffc4ca3eb4d54f66885b72f660a66c5f- Stable URL of this page
https://metraipolis.com/documento/dc_d6bf545e86e6
How to cite
Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2… — Europe PMC PMID:42420629 — Europe PMC (en), https://europepmc.org/article/MED/42420629 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d6bf545e86e6 (Metraipolis archive dc_d6bf545e86e6, sha256 2060f48a9976805abdc9f668873df9e4ffc4ca3eb4d54f66885b72f660a66c5f)
BibTeX
@misc{dcd6bf545e86e6,
title = {Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2… — Europe PMC PMID:42420629},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42420629},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d6bf545e86e6; sha256 2060f48a9976805abdc9f668873df9e4ffc4ca3eb4d54f66885b72f660a66c5f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42420629. Agents can read the archived copy with the MCP tool read_document.